Clinical Research Directory
Browse clinical research sites, groups, and studies.
HIV Prevention With PrEP Among People on Opioid Replacement Therapy
Sponsor: Cara Spence
Summary
The purpose of this study is to assess the feasibility and acceptability of providing oral pre-exposure prophylaxis (PrEP) and opioid agonist therapy (OAT) simultaneously in existing pharmacy-based programs operating in Alberta and Saskatchewan, to collect preference, adherence, and persistence data on oral PrEP, and to assess interest / acceptability of long-lasting injectable options for human immunodeficiency virus (HIV) prevention.
Official title: Improving Access to HIV Pre-exposure Prophylaxis: Implementation and Evaluation of Innovative HIV Prevention Services Among Persons on Opioid Replacement Therapy in Western Canada: Prospective, Implementation Study
Key Details
Gender
All
Age Range
16 Years - Any
Study Type
INTERVENTIONAL
Enrollment
350
Start Date
2025-08-28
Completion Date
2027-09-01
Last Updated
2025-10-07
Healthy Volunteers
Yes
Conditions
Interventions
Simultaneous administration of OAT and oral PrEP at existing pharmacy-based programs
Simultaneous administration of OAT and oral PrEP (direct observed therapy or home supply) at existing pharmacy-based programs
Locations (6)
Sheldon M Chumir Health Centre
Calgary, Alberta, Canada
Queen City Wellness Pharmacy
Regina, Saskatchewan, Canada
Mayfair Drugs Pharmacy
Saskatoon, Saskatchewan, Canada
Pharmasave Riversdale Pharmacy
Saskatoon, Saskatchewan, Canada
The Medicine Shoppe Pharmacy
Saskatoon, Saskatchewan, Canada
Meadowgreen Pharmacy
Saskatoon, Saskatchewan, Canada